Cell and Gene Therapy Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Services, Scale, Service Providers, End User, and Geography

List of Tables

The cell and gene therapy market is expected to grow from US$ 4,485.00 million in 2023 to US$ 28,050.39 million by 2031; it is anticipated to record a CAGR of 25.8% from 2023 to 2031.

Key segments that contributed to the derivation of the cell and gene therapy market analysis are services, scale, service providers, and end user.

The cell and gene therapy market, by type, the cell and gene therapy market is segmented into bifurcated into cell therapy, gene therapy. The cell therapy segment held a larger market share in 2023. Cell therapy helps treat disorders and diseases by restoring or changing certain groups of cells or providing cells to carry therapy through the body. Cell therapy forms or modifies cells outside the body before introducing into the patient. The cells might derive from the patient (autologous cells) or a donor (allogeneic cells). The growth of the cell therapy segment is attributed to the increasing number of products entering the market, the potential application of cell therapies in treating autoimmune diseases, cancer, and infectious diseases, and the high number of ongoing clinical trials.

The cell and gene therapy market, by services, the market is segmented into process development, cGMP manufacturing, regulatory services, bioassay services. The process development segment held a larger share of the market in 2023. The cell and gene therapy market is witnessing rapid growth driven by technological advancements, particularly in manufacturing and delivery services. With such advancements, cell and gene therapy developers offer expertise in developing robust and scalable manufacturing processes, ensuring high-quality product consistency, and optimizing delivery methods for specific therapeutic targets.

By type, the market is segmented into vented and non-vented. The vented segment held a larger share of the market in 2023.

The cell and gene therapy market, by scale, the market is bifurcated into pre commercial/R and D manufacturing, commercial scale manufacturing. The pre commercial/R and D manufacturing segment held a larger share of the market in 2023.

The cell and gene therapy market, by service provider, the market is divided into CDMOs, CMOs. The CDMOs segment held a larger share of the market in 2023.

The cell and gene therapy market, by end user, the market is segmented into contract research organizations, pharmaceutical and biopharmaceutical companies, academic and research institutes. The pharmaceutical and biopharmaceutical companies segment dominated the market in 2023.

The scope of the cell and gene therapy market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, Japan, India, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). In terms of revenue, North America accounted for the largest market share in 2023. On the other hand, Asia Pacific region accounted for the fastest-growing global cell and gene therapy market in 2023. China is making progress in gene and cell therapy. The country has a large patient population making it an attractive market for companies developing these treatments. Several companies are working on innovative therapies for diseases such as cancer and genetic disorders in China, and the country has invested heavily in gene therapy research and development. China was the first country to approve gene therapy in 2003; since then, cell and gene therapy developments have advanced rapidly worldwide, and their therapeutic potential has soared. The government of the People's Republic of China has conducted several regulatory reforms to promote the normative development of cell and gene therapies. In addition, the presence of various market leaders operating in the segments is contributing to the market expansion, which contribute notably to the expansion of cell and gene therapy market size.

European Union (EU), Organisation for Economic Co-operation and Development (OECD), and National Library of Medicine (NLM) are a few key primary and secondary sources referred to while preparing the report on the cell and gene therapy market.

Product Code: TIPRE00020854

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Cell and Gene Therapy Market Landscape

4.1 Overview
4.2 PEST Analysis

5. Cell and Gene Therapy Market - Key Market Dynamics

5.1 Cell and Gene Therapy Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increase in Number of Approval of Cell and Gene Therapies
- 5.2.2 Rapid Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.3 Market Restraints
- 5.3.1 High Cost of Cell and Gene Therapy Manufacturing
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Companies
5.5 Future Trends
- 5.5.1 Automation of Cell and Gene Therapy Manufacturing Services
5.6 Impact of Drivers and Restraints:

6. Cell and Gene Therapy Market - Global Market Analysis

6.1 Cell and Gene Therapy Market Revenue (US$ Million), 2021-2031
6.2 Cell and Gene Therapy Market Forecast Analysis

7. Cell and Gene Therapy Market Analysis - by Type

7.1 Cell Therapy
- 7.1.1 Overview
- 7.1.2 Cell Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

8. Cell and Gene Therapy Market Analysis - by Services

8.1 Process Development
- 8.1.1 Overview
- 8.1.2 Process Development: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.2 cGMP Manufacturing
- 8.2.1 Overview
- 8.2.2 cGMP Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Regulatory Services
- 8.3.1 Overview
- 8.3.2 Regulatory Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Bioassay Services
- 8.4.1 Overview
- 8.4.2 Bioassay Services: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

9. Cell and Gene Therapy Market Analysis - by Scale

9.1 Pre Commercial/R and D Manufacturing
- 9.1.1 Overview
- 9.1.2 Pre Commercial/R and D Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
9.2 Commercial Scale Manufacturing
- 9.2.1 Overview
- 9.2.2 Commercial Scale Manufacturing: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

10. Cell and Gene Therapy Market Analysis - by Service Providers

10.1 CDMOs
- 10.1.1 Overview
- 10.1.2 CDMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
10.2 CMOs
- 10.2.1 Overview
- 10.2.2 CMOs: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

11. Cell and Gene Therapy Market Analysis - by End User

11.1 Contract Research Organizations
- 11.1.1 Overview
- 11.1.2 Contract Research Organizations: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.2 Pharmaceutical and Biopharmaceutical Companies
- 11.2.1 Overview
- 11.2.2 Pharmaceutical and Biopharmaceutical Companies: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
11.3 Academic and Research Institutes
- 11.3.1 Overview
- 11.3.2 Academic and Research Institutes: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)

12. Cell and Gene Therapy Market - Geographical Analysis

12.1 Overview
12.2 North America
- 12.2.1 North America Cell and Gene Therapy Market Overview
- 12.2.2 North America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.2.3 North America: Cell and Gene Therapy Market Breakdown, by Type
  - 12.2.3.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.2.3.1.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.2.3.1.2 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.2.4 North America: Cell and Gene Therapy Market Breakdown, by Services
  - 12.2.4.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.2.5 North America: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.2.5.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.2.6 North America: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.2.6.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.2.7 North America: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.7.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.2.8 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.1 North America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.2.8.2 United States: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.2.1 United States: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.2.1.1 United States: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.2.1.2 United States: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.2.2 United States: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.2.3 United States: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.2.4 United States: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.2.5 United States: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.8.3 Canada: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.3.1 Canada: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.3.1.1 Canada: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.3.1.2 Canada: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.3.2 Canada: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.3.3 Canada: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.3.4 Canada: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.3.5 Canada: Cell and Gene Therapy Market Breakdown, by End User
  - 12.2.8.4 Mexico: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.2.8.4.1 Mexico: Cell and Gene Therapy Market Breakdown, by Type
    - 12.2.8.4.1.1 Mexico: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.2.8.4.1.2 Mexico: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.2.8.4.2 Mexico: Cell and Gene Therapy Market Breakdown, by Services
    - 12.2.8.4.3 Mexico: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.2.8.4.4 Mexico: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.2.8.4.5 Mexico: Cell and Gene Therapy Market Breakdown, by End User
12.3 Europe
- 12.3.1 Europe Cell and Gene Therapy Market Overview
- 12.3.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.3.3 Europe: Cell and Gene Therapy Market Breakdown, by Type
  - 12.3.3.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.3.3.1.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.3.3.1.2 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.3.4 Europe: Cell and Gene Therapy Market Breakdown, by Services
  - 12.3.4.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.3.5 Europe: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.3.5.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.3.6 Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.3.6.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.3.7 Europe: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.7.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.3.8 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.1 Europe: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.3.8.2 United Kingdom: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.2.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.2.1.1 United Kingdom: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.2.1.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.2.2 United Kingdom: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.2.3 United Kingdom: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.2.4 United Kingdom: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.2.5 United Kingdom: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.3 Germany: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.3.1 Germany: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.3.1.1 Germany: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.3.1.2 Germany: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.3.2 Germany: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.3.3 Germany: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.3.4 Germany: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.3.5 Germany: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.4 France: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.4.1 France: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.4.1.1 France: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.4.1.2 France: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.4.2 France: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.4.3 France: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.4.4 France: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.4.5 France: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.5 Italy: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.5.1 Italy: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.5.1.1 Italy: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.5.1.2 Italy: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.5.2 Italy: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.5.3 Italy: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.5.4 Italy: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.5.5 Italy: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.6 Spain: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.6.1 Spain: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.6.1.1 Spain: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.6.1.2 Spain: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.6.2 Spain: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.6.3 Spain: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.6.4 Spain: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.6.5 Spain: Cell and Gene Therapy Market Breakdown, by End User
  - 12.3.8.7 Rest of Europe: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.3.8.7.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Type
    - 12.3.8.7.1.1 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.3.8.7.1.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.3.8.7.2 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Services
    - 12.3.8.7.3 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.3.8.7.4 Rest of Europe: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.3.8.7.5 Rest of Europe: Cell and Gene Therapy Market Breakdown, by End User
12.4 Asia Pacific
- 12.4.1 Asia Pacific Cell and Gene Therapy Market Overview
- 12.4.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.4.3 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Type
  - 12.4.3.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.4.3.1.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.4.3.1.2 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.4.4 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Services
  - 12.4.4.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.4.5 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.4.5.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.4.6 Asia Pacific: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.4.6.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.4.7 Asia Pacific: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.7.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.4.8 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.1 Asia Pacific: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.4.8.2 China: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.2.1 China: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.2.1.1 China: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.2.1.2 China: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.2.2 China: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.2.3 hina: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.2.4 China: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.2.5 China: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.3 Japan: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.3.1 Japan: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.3.1.1 Japan: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.3.1.2 Japan: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.3.2 Japan: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.3.3 Japan: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.3.4 Japan: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.3.5 Japan: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.4 India: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.4.1 India: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.4.1.1 India: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.4.1.2 India: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.4.2 India: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.4.3 India: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.4.4 India: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.4.5 India: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.5 Australia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.5.1 Australia: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.5.1.1 Australia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.5.1.2 Australia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.5.2 Australia: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.5.3 Australia: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.5.4 Australia: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.5.5 Australia: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.6 South Korea: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.6.1 South Korea: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.6.1.1 South Korea: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.6.1.2 South Korea: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.6.2 South Korea: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.6.3 South Korea: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.6.4 South Korea: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.6.5 South Korea: Cell and Gene Therapy Market Breakdown, by End User
  - 12.4.8.7 Rest of APAC: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.4.8.7.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Type
    - 12.4.8.7.1.1 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.4.8.7.1.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.4.8.7.2 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Services
    - 12.4.8.7.3 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.4.8.7.4 Rest of APAC: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.4.8.7.5 Rest of APAC: Cell and Gene Therapy Market Breakdown, by End User
12.5 Middle East and Africa
- 12.5.1 Middle East and Africa Cell and Gene Therapy Market Overview
- 12.5.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.5.3 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
  - 12.5.3.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.5.3.1.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.5.3.1.2 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.5.4 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
  - 12.5.4.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.5.5 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.5.5.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.5.6 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.5.6.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.5.7 Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.7.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.5.8 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.1 Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.5.8.2 South Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.2.1 South Africa: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.2.1.1 South Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.2.1.2 South Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.2.2 South Africa: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.2.3 South Africa: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.2.4 South Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.2.5 South Africa: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.3 Saudi Arabia: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.3.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.3.1.1 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.3.1.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.3.2 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.3.3 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.3.4 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.3.5 Saudi Arabia: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.4 United Arab Emirates: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.4.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.4.1.1 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.4.1.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.4.2 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.4.3 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.4.4 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.4.5 United Arab Emirates: Cell and Gene Therapy Market Breakdown, by End User
  - 12.5.8.5 Rest of Middle East and Africa: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.5.8.5.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Type
    - 12.5.8.5.1.1 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.5.8.5.1.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.5.8.5.2 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Services
    - 12.5.8.5.3 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.5.8.5.4 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.5.8.5.5 Rest of Middle East and Africa: Cell and Gene Therapy Market Breakdown, by End User
12.6 South and Central America
- 12.6.1 South and Central America Cell and Gene Therapy Market Overview
- 12.6.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
- 12.6.3 South and Central America: Cell and Gene Therapy Market Breakdown, by Type
  - 12.6.3.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Type
    - 12.6.3.1.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Cell Therapy
    - 12.6.3.1.2 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Gene Therapy
- 12.6.4 South and Central America: Cell and Gene Therapy Market Breakdown, by Services
  - 12.6.4.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Services
- 12.6.5 South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
  - 12.6.5.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Scale
- 12.6.6 South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
  - 12.6.6.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Service Providers
- 12.6.7 South and Central America: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.7.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by End User
- 12.6.8 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.1 South and Central America: Cell and Gene Therapy Market - Revenue and Forecast Analysis - by Country
  - 12.6.8.2 Brazil: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.2.1 Brazil: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.2.1.1 Brazil: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.2.1.2 Brazil: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.2.2 Brazil: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.2.3 Brazil: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.2.4 Brazil: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.2.5 Brazil: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.8.3 Argentina: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.3.1 Argentina: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.3.1.1 Argentina: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.3.1.2 Argentina: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.3.2 Argentina: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.3.3 Argentina: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.3.4 Argentina: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.3.5 Argentina: Cell and Gene Therapy Market Breakdown, by End User
  - 12.6.8.4 Rest of South and Central America: Cell and Gene Therapy Market - Revenue and Forecast to 2031 (US$ Million)
    - 12.6.8.4.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Type
    - 12.6.8.4.1.1 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Cell Therapy
    - 12.6.8.4.1.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Gene Therapy
    - 12.6.8.4.2 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Services
    - 12.6.8.4.3 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Scale
    - 12.6.8.4.4 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by Service Providers
    - 12.6.8.4.5 Rest of South and Central America: Cell and Gene Therapy Market Breakdown, by End User

13. Industry Landscape

13.1 Overview
13.2 Growth Strategies in Cell and Gene Therapy Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Thermo Fisher Scientific Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Merck KGaA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Charles River Laboratories International Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Cell and Gene Therapy Catapult
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Lonza Group AG
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 WuXi AppTec Co Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Takara Bio Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 FUJIFILM Holdings Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 F. Hoffmann-La Roche Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Catalent Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Lotte Corp
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms